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Abstract: The CpCo(CO)2-catalyzed cocyclization of 1,2-diethy-
nyl-4-methoxybenzene with alkynes can be applied to the synthesis
of ‘spacer’-naproxen [2-(6-methoxybiphenylen-2-yl)propanoic ac-
id] and its 7-methoxy isomer, ‘spacer’-isonaproxen. While unsym-
metrical alkynes are incorporated without regioselectivity, the
methoxy group in 6-methoxy-2,3-bis(trimethylsilyl)biphenylene
directs electrophiles to C-3, thus allowing for regiochemical differ-
entiation between the 2- and 3-positions.
Key words: alkynes, cobalt, cyclization, carbocycles, regioselec-
tivity
Dimensional probes in the form of structural spacers sep-
arating functional units have been used in various areas of
structure–activity correlations. The smallest spacer be-
tween two rings is two bonds, in the case of aromatic cy-
cles engendering a cyclobutadiene core. From this
perspective, biphenylene is ‘spacer’-naphthalene. This
motif has been exploited to investigate electron-transfer
mechanisms between electroactive units,1 bidentate
Lewis and Brønsted acid effects,2 potential utility in su-
pramolecular assembly,3 steric interference,4 spatial
boundaries for biomolecular interactions,5 and novel drug
topologies.6 In tune with continuing interest in the devel-
opment of new cyclooxygenase (Cox) inhibitors,7 we re-
port the synthesis of the spacer analogues of the anti-
inflammatory drug naproxen (1)8 and its regioisomer
isonaproxen, namely compounds 2 and 3 (Figure 1), and
the preliminary biological evaluation of the former.
The strategy for their construction was based on our co-
balt-catalyzed assembly of biphenylenes by alkyne
cyclotrimerization9 and the hitherto unexplored potential
of remote substituents on its regiochemical control.10
The work began with a test of the basic feasibility of the
approach featuring 2-(biphenylen-2-yl)acetic acid 4 as the
target. The two reported syntheses of this molecule6k,11
suffer from the need for biphenylene as the starting mate-
rial.12 A more convergent execution is depicted in
Scheme 1, which entails the CpCo(CO)2-catalyzed cocy-
clization of diyne 59b with an excess of the homopropargyl
alcohol/ether substrates 6 (6a, neat; 6b, 4 equiv in THF;
6c, 5 equiv in THF). Fully silylated 6c fared best, afford-
ing 7c in 52% yield. Compound 7c was in turn deprotect-
ed with fluoride and oxidized with pyridinium




Next was the task of establishing the efficacy, in addition
to regioselectivity, of cycloadditions to the methoxy-bear-
ing diyne 815 to alkynes 9 (Scheme 2). The corresponding
biphenylenes 10 ensued in reasonable to good yields.14
Disappointingly, however, the unsymmetrical substrates
9b and 9c led to the two regioisomers A and B of 10b and
10c, respectively, as an unseparated equimolar mixture.
What is the origin of this outcome? Mechanistically, it is
likely that initial cobaltacyclopentadiene formation in-
volves intermolecular coupling of 9 with either one of the
diyne units of 8 to give C or D (Scheme 2), in this way de-
ferring formation of the strained ring until the final step of
the cyclotrimerization.16,17 Moreover, it is expected that
the bulky TMS group will emerge positioned a to Co in
this transformation. Therefore, the indiscriminate emer-
gence of A and B in Scheme 2 signals that the triple bonds



















6a, R1 = R2 = H
6b, R1 = H, R2 = SiMe3
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erating equal amounts of C and D, thus establishing the
absence of any remote electronic effect of the MeO group
on this step.
Scheme 2
The lack of regioselectivity in the formation of 10b and
10c notwithstanding, we forged ahead with 10c in an at-
tempt to complete the syntheses of the target compounds,
relying on established sequences toward anti-inflammato-
ry 2-arylpropanoic acids.8,18 For this purpose, 10c was
first desilylated with TBAF (THF, 92%) to render 11. At-
tempted direct cyanation19 generated only ethenylbiphe-
nylene derivatives 12 (Scheme 3), but an indirect route,20
via acetates 13, succeeded in attaining 14.14 While prelim-
inary small-scale experiments indicated the formation of
mixtures of 2 and 3 on nitrile hydrolysis, this approach
was abandoned, because of the failure to separate the re-
gioisomers at any step along the sequence and because a
solution to the regioselectivity problem was found, as de-
scribed next.
The key to the selective synthesis of 2 and 3 was the
directing influence of the 6-methoxy substituent on the
regioselectivity of attack by electrophiles at C-3 in the
bis(trimethylsilyl)derivative 10a.21 Thus, quantitative
low-temperature protodesilylation with TFA produced 15
(Scheme 4) admixed with small amounts of its regioiso-
mer (86:14), from which 15 was removed by fractional
crystallization.14 The position of the silyl group was ascer-
tained by 2D NMR correlation spectroscopy, necessitat-
ing the complete assignment of both 1H and 13C spectra.14
Chemical confirmation was attained by hydrogenolysis of
the four-membered ring bonds (Ra-Ni, EtOH, heat,
57%)21 leading to 4-methoxy-3¢-(trimethylsilyl)- and 3-
methoxy-4¢-(trimethylsilyl)biphenyl, separated by GC
and identified by the respective presence of only one
para- and one meta-substituted phenyl group in each (1H
NMR). The regioisomer of 15 would have led to bis-para-
and bis-meta-substituted biphenyls, clearly incompatible
with the observed data.14
With 15 in hand, the synthesis of ‘spacer’-naproxen 2 was
completed as depicted in Scheme 4. Thus, base-
mediated22 iododesilylation furnished 16, which was
alkynylated to 17 and then converted to acid 18 following
Zweifel’s procedure.23 Finally, methylation provided the
desired target in good overall yield.14
Scheme 4
The directing power of the methoxy substituent is also ef-
fective in the synthesis of the regioisomeric series corre-
sponding to that in Scheme 4 by simply inverting the







8 9a, R = SiMe
3
9b, R = Et
9c, R = CH(OH)Me
R
10a, R = SiMe
3
, 72%
10b, R = Et, 50% 
       (A/B = 1:1)
10c, R = CH(OH)Me, 52% 
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Hence, iododesilylation with ICl–pyridine complex24 fur-
nished 19 exclusively, which, on treatment with acid, de-
livered 20. From there, ‘spacer’-isonaproxen 3 was
readily assembled through the intermediacy of 21 and
22.14
‘Spacer’-naproxen 2 was tested in vitro for its effects on
lipoxygenase and cyclooxygenase. It was inactive against
the former, but as active as naproxen against the latter.
However, in vivo oral testing failed to show any cyclo-
oxygenase inhibitory function, possibly a result of poor
absorption or rapid metabolism.
To summarize, we have found that a 4-methoxy group in
ortho-diethynylbenzene has no influence on the regio-
selectivity of the cobalt-catalyzed [2+2+2] cycloaddition
with unsymmetrical alkynes. In contrast, this group at C-
6 of the biphenylene nucleus allows the selective stepwise
replacement of the silyl groups of the 2,3-bis(trimethyl-
silylated) second arene ring by electrophiles. This feature
significantly expands the accessibility of specifically sub-
stituted  biphenylenes, as demonstrated by the syntheses
of the biphenylene analogues of naproxen and isonaprox-
en.
Supporting Information for this article is available online at
http://www.thieme-connect.com/ejournals/toc/synlett.
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